Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WCLC Sept 2021 | Participant selection for lung cancer screening

David Baldwin, MD, FRCP, Nottingham University Hospitals, Nottingham, UK, provides an overview of his presentation at the World Conference on Lung Cancer (WCLC) 2021 on the landscape of eligibility and participant selection for lung cancer screening. In his presentation, he describes a range of eligibility criteria and multivariate models used for participant selection and discusses behavioural research into the factors impacting participant enrolment in lung cancer screening programs. This interview took place at the WCLC 2021.

Transcript (edited for clarity)

Yeah, so my talk’s really about the importance of selection for screening, selecting the correct people. And it’s entitled The Landscape of Selection, which is a subtitle, but very, very important. And it’s not just about the methods that you might use to select people. In other words, things like age, sex criteria and multivariable models. That’s one very important element of it and this is discussed in my talk, the pros and cons of using standard age and sex criteria versus multivariable models...

Yeah, so my talk’s really about the importance of selection for screening, selecting the correct people. And it’s entitled The Landscape of Selection, which is a subtitle, but very, very important. And it’s not just about the methods that you might use to select people. In other words, things like age, sex criteria and multivariable models. That’s one very important element of it and this is discussed in my talk, the pros and cons of using standard age and sex criteria versus multivariable models. But it’s also about making sure that you include all of the other very important eligibility criteria, because really what you’re trying to do is you’re trying to select people who will benefit from the intervention and people that also want to participate when they have fully informed explanations to what actually going to happen to them, what the consequences might be.

So all of these things are very important, and I sort of finish off a bit about some work that’s been done by a lot of behavioral psychologists on behavior change in a way to try to get the person who’s looking at this presentation to reflect on what it is that gets people to actually participate in screening programs and how you might influence that in a positive way to get them to do something that they actually sign up to do and continue on in the program to get the maximum benefit.

Read more...

Disclosures

David Baldwin has received honoraria for advice and education sessions from AZ, MSD, BMS and Roche.